Literature DB >> 8606921

Induction and phosphorylation of protein kinase C-alpha and mitogen-activated protein kinase by hypoxia and by radiation in Chinese hamster V79 cells.

N M Hasan1, P J Parker, G E Adams.   

Abstract

Protein kinase C (PKC) and mitogen-activated protein (MAP) kinase are protein-serine/threonine kinases which are important regulators of diverse cellular processes including metabolism, proliferation and differentiation. This study shows that both hypoxia and X irradiation of serum-deprived Chinese hamster V79 cells cause the induction and phosphorylation of the PKC-alpha isoform. The increased induction and phosphorylation of PKC occur mainly in the nuclear fraction. Unlike the PKC activator TPA, neither hypoxic nor radiation stress causes translocation of PKC-alpha from the cytosol to the membrane. The induction of PKC-alpha by hypoxia is accompanied by an increased expression of MAP kinase but, in contrast, this does not occur when PKC-alpha is induced by radiation. Radiation, like TPA, causes a complete redistribution of MAP kinase from the cytosol to the nucleus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606921

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  TLR4 mutation and HSP60-induced cell death in adult mouse cardiac myocytes.

Authors:  J P Heiserman; L Chen; B S Kim; S C Kim; A L Tran; N Siebenborn; A A Knowlton
Journal:  Cell Stress Chaperones       Date:  2015-02-27       Impact factor: 3.667

2.  Protein kinase C epsilon is involved in ionizing radiation induced bystander response in human cells.

Authors:  Burong Hu; Bo Shen; Yanrong Su; Charles R Geard; Adayabalam S Balajee
Journal:  Int J Biochem Cell Biol       Date:  2009-07-03       Impact factor: 5.085

3.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability.

Authors:  N M Hasan; G E Adams; M C Joiner; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.